{"id":41478,"date":"2019-05-20T14:13:18","date_gmt":"2019-05-20T18:13:18","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=41478"},"modified":"2019-05-30T13:44:55","modified_gmt":"2019-05-30T17:44:55","slug":"reverse-split-salvages-nasdaq-listing-for-auris-medical","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478","title":{"rendered":"Reverse Split Salvages Nasdaq Listing for Auris Medical"},"content":{"rendered":"<p>At the end of April, Auris Medical Holding (NASDAQ: EARS) said that it was performing a 1-for-20 reverse split of its stock, effective at the start of this month.\u00a0\u00a0\u00a0The share consolidation was underpinned by warnings from Nasdaq that the Switzerland-based company was facing delisting because its stock price was below the minimum bid threshold per Nasdaq Global Market continued listing guidelines.<br \/>\nThe reverse split took the number of outstanding shares of EARS from 38.1 million to only about 1.9 million.\u00a0\u00a0Upon the execution of the split, shares moved from about 28 cents to approximately $5.60 each.\u00a0\u00a0<br \/>\nAs often happens, the reverse split was not well received by Wall Street, especially when Auris came right behind the split by adding more shares to the market to raise capital.\u00a0Last week, Auris closed a public offering (raising about $8 million) where it would more than triple its outstanding share count if all warrants are exercised.<br \/>\nTrader\u2019s attention has been glued to the dilution rather than Auris recently acquiring two U.S. patents related to the use of the small molecule betahistine for treating depression and attention deficit\/hyperactivity disorder (ADHD).<br \/>\nAuris specializes in betahistine, a drug that is approved for vertigo and Meniere\u2019s disease in over 100 countries, but not the U.S.\u00a0\u00a0The company is working to complete early stage work in its development of intranasal betahistine to improve known bioavailability limitations as a new drug for vertigo (AM-125) and for the prevention of antipsychotic-induced weight gain and somnolence (AM-201).<br \/>\nA phase 1b clinical trial of AM-201 being conducted in Europe for the prevention of antipsychotic-induced weight gain and somnolence reached its enrollment midpoint this month with the 25<sup>th<\/sup>patient entering the dose-escalation study.\u00a0Top-line data from the trial is expected next quarter.<br \/>\nElsewhere in the pipeline, Auris has phase 3 studies going for Sonsuvi (AM-111) for acute inner ear hearing loss and Keyzilen (AM-101) for acute inner ear tinnitus, indications that explain the company\u2019s ticker symbol.<br \/>\nShares hit an all-time low last week at $3.00.\u00a0\u00a0To put that in perspective, shares of EARS (on a split-adjusted basis) were around $190 as recently as November 2017 and even near $1,600 at the start of 2016.\u00a0The stock gapped up to start trading on Monday, opening at $3.42 after closing Friday at $3.12 on news that Nasdaq has officially recognized Auris has regained compliance with its minimum bid requirement thanks to the reverse split.<br \/>\nAn hour into the session, however, shares have slipped into the red to print $3.06 for a loss of 1.9%.<br \/>\nDisclosure: The views and opinions expressed in this article are those of the authors, and do not represent the views of WallStreetPR.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.\u00a0 WallStreetPR.com has not been compensated for publishing this post.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At the end of April, Auris Medical Holding (NASDAQ: EARS) said that it was performing a 1-for-20 reverse split of its stock, effective at the [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":41479,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,3],"tags":[13552,13557,13554,13555,13556,13558],"stock_ticker":[],"class_list":["post-41478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-small-cap-stock-news","tag-auris-medical","tag-auris-medical-news","tag-ears","tag-ears-stock","tag-small-cap-news","tag-small-cap-stocks","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"At the end of April, Auris Medical Holding (NASDAQ: EARS) said that it was performing a 1-for-20 reverse split of its stock, effective at the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-20T18:13:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-30T17:44:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"460\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Reverse Split Salvages Nasdaq Listing for Auris Medical\",\"datePublished\":\"2019-05-20T18:13:18+00:00\",\"dateModified\":\"2019-05-30T17:44:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\"},\"wordCount\":473,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg\",\"keywords\":[\"Auris Medical\",\"Auris Medical news\",\"EARS\",\"EARS stock\",\"small cap news\",\"small cap stocks\"],\"articleSection\":[\"Health\",\"Small Cap Stock News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\",\"name\":\"Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg\",\"datePublished\":\"2019-05-20T18:13:18+00:00\",\"dateModified\":\"2019-05-30T17:44:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg\",\"width\":800,\"height\":460,\"caption\":\"Auris Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reverse Split Salvages Nasdaq Listing for Auris Medical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478","og_locale":"en_US","og_type":"article","og_title":"Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR","og_description":"At the end of April, Auris Medical Holding (NASDAQ: EARS) said that it was performing a 1-for-20 reverse split of its stock, effective at the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2019-05-20T18:13:18+00:00","article_modified_time":"2019-05-30T17:44:55+00:00","og_image":[{"width":800,"height":460,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Reverse Split Salvages Nasdaq Listing for Auris Medical","datePublished":"2019-05-20T18:13:18+00:00","dateModified":"2019-05-30T17:44:55+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478"},"wordCount":473,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg","keywords":["Auris Medical","Auris Medical news","EARS","EARS stock","small cap news","small cap stocks"],"articleSection":["Health","Small Cap Stock News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478","url":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478","name":"Reverse Split Salvages Nasdaq Listing for Auris Medical - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg","datePublished":"2019-05-20T18:13:18+00:00","dateModified":"2019-05-30T17:44:55+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/05\/HEAR.jpg","width":800,"height":460,"caption":"Auris Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/reverse-split-salvages-nasdaq-listing-for-auris-medical-41478#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Reverse Split Salvages Nasdaq Listing for Auris Medical"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/41478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=41478"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/41478\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/41479"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=41478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=41478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=41478"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=41478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}